直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
Lilly Karim-Nejad
Associate
More
vCard
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
+1 202 408 4483
lilly.karim-nejad@finnegan.com lilly.karim-nejad@finnegan.com

Lilly Karim-Nejad

Associate

  • +1 202 408 4483 +1 202 408 4483
  • lilly.karim-nejad@finnegan.com lilly.karim-nejad@finnegan.com
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
  • vCard

Lilly Karim-Nejad focuses on district court litigation and proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO). She works with clients across a variety of industries, with an emphasis on those in the pharmaceutical and biotechnology fields.

 

While in law school, Lilly worked at Finnegan as a summer associate, assisting with litigation matters before federal district courts and dedicating her time to pro bono matters. She participated in the Giles Sutherland Rich Moot Court Competition, through which she was recognized for her appellate briefs, and was a member of the Intellectual Property Law Society.

 

Et Cetera

  • Recipient, Giles Sutherland Rich Award for Excellence in the Study of Intellectual Property Law, George Mason University Antonin Scalia Law School, 2025.

Insights

Federal Circuit IP Blog

Federal Circuit Affirms Finding that “Best” or “Optimal” Language in Claims Is Indefinite Federal Circuit Affirms Finding that “Best” or “Optimal” Language in Claims Is Indefinite

January 14, 2026

Admissions and Education

Admissions

  • U.S. Patent and Trademark Office
  • District of Columbia

Education

Antonin Scalia Law School at George Mason University
J.D., 2025
George Mason University
B.S., Biology,

magna cum laude, 2021

Languages

  • Farsi

Lilly's Practices

Global IP Enforcement, Litigation, and Trials
Patent Litigation and Trials
Prosecution and Portfolio Management
Appeals to the PTAB
Design Rights

Lilly's Industries

Chemicals, Industrials, and Materials
Chemical
Life Sciences
Biotechnology
Pharmaceutical

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP